HSAQ
Health Sciences Acquisitions Corporation 2
Set alert
13.31 0.00 0.00%
10.44 Day range 13.50
9.41 52-week range 13.80
- Open
- 10.80
- Prev close
- 13.31
- Mkt cap
- 149.23M
- Vol
- 119.61K
- Avg vol
- 70.10K
- EPS
- -0.035
- P/E
- -532.40
- Div yield
- 0.00%
More statistics
- Low
- 10.44
- High
- 13.50
- Forward P/E
- 0.00
- Beta
- 0.08
- Short ratio
- 4.62
- Inst. own
- 52.23%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 10.06
- 200-d avg
- 9.96
- 1y target
- 0.00
Financial health
Altman Z-Score
-3.04 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -12.0×
FY 2020 5y median -66.5× FY 2025
P/S 15262×
FY 2020 5y median 0.0× FY 2025
P/B 9539×
FY 2020 5y median 1.7× FY 2025
P/FCF -10333×
FY 2020 5y median -1005× FY 2025
EV/EBITDA -9863×
FY 2020 5y median -535× FY 2025
EV/Sales 15261×
FY 2020 5y median 0.0× FY 2025
FCF Yield -0.0%
FY 2020 5y median -0.1% FY 2025
Profitability
Gross Margin 99.4%
FY 2020 5y median 0.0% FY 2025
Operating Margin -154.7%
FY 2020 5y median 0.0% FY 2025
Net Margin -158.2%
FY 2020 5y median 0.0% FY 2025
ROE -98.9%
FY 2020 5y median -0.1% FY 2025
ROIC -52.4%
FY 2020 5y median -4.1% FY 2025
ROA -46.1%
FY 2020 5y median -3.5% FY 2025
Growth (YoY)
Revenue 1169.2%
FY 2020 FY 2025
Operating Income 19.4%
FY 2020 FY 2025
EPS (diluted) 33.1%
FY 2020 FY 2025
Free Cash Flow 2.7%
FY 2020 FY 2025
Financial Health
Current Ratio 6.4×
FY 2020 5y median 6.4× FY 2025
Quick Ratio 6.4×
FY 2020 5y median 6.4× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2020 5y median 0.6× FY 2025
Interest Coverage 45.1×
FY 2020 5y median 8.9× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31